Trinity Capital Commits $35 Million Growth Capital to Neuros Medical to Scale Altius Pain Therapy Adoption

EQT Life Sciences and LSP 7 Lead $56M Series D in Neuros Medical

July 9, 2025

Medical Devices

EQT Life Sciences, together with the LSP 7 fund and EQT Health Economics strategy, co-led a $56 million Series D financing in Neuros Medical to support U.S. commercialization of the Altius direct electrical nerve stimulation system for chronic post-amputation pain. Proceeds will fund scaling of commercial operations to expand access to the FDA‑approved, non‑opioid treatment for adult amputees.

Concord Health Partners Leads Growth Financing in Accelus

May 29, 2025

Medical Devices

Accelus, a Palm Beach Gardens-based medical technology company specializing in expandable spinal implant technologies, closed a new equity financing round led by healthcare-focused investment firm Concord Health Partners. The capital will support Accelus's U.S. commercial expansion and further development of its spinal implant product pipeline.

Gyrus Capital Leads $68M Equity Investment in Neo Medical

September 17, 2024

Medical Devices

Swiss private equity firm Gyrus Capital led a strategic equity investment of up to $68 million (CHF 58 million) into Swiss medical-technology company Neo Medical SA, with participation from existing investors including Swisscom Ventures, Verve Ventures, 4FO and Credit Suisse Entrepreneur Capital as well as the founders. The financing will fund Neo Medical’s US expansion, deployment of new spine surgery products, and further development of its AI-driven augmented reality intraoperative platform ADVISE.

Capitol Pain Institute (Iron Path Capital-backed) Acquires Nura Pain Clinics

May 3, 2023

Healthcare Services

Capitol Pain Institute (CPI), backed by private equity firm Iron Path Capital, has acquired Nura Pain Clinics to enter the Minneapolis–St. Paul market and expand CPI's national chronic pain platform into Minnesota. The transaction adds Nura's interventional pain management clinics and ambulatory surgical capabilities to CPI's network, broadening access to neuromodulation and implantable pain therapies in the Midwest.

Ampersand Capital Partners Invests in AnaBios Corporation

June 7, 2022

Healthcare Services

Ampersand Capital Partners has made a growth equity investment in San Diego-based AnaBios Corporation, a preclinical contract research organization specializing in translational research using human tissues. The investment will be used to expand AnaBios’s capabilities, therapeutic area coverage and global reach to support more successful drug discovery and development programs.

St. Cloud Capital Makes Growth Investment in AleraCare

May 8, 2019

Healthcare Services

St. Cloud Capital, a Los Angeles-based private investment firm, announced a growth capital investment in AleraCare Holdings, LLC, a combined provider of specialty pharmacy, home infusion and ambulatory infusion services (MedicoRx, Vasco Infusion and VascoRx). The financing refinanced existing senior debt, supported a new ABL facility, and will fund capital investments to expand the combined company's capabilities and geographic presence across the western United States.